Joseph Kibirige
Research Subjects
Joseph Kibirige has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Sanjeev R. Acharya
3 shared publications- Patrick Maduabuchi Aja
Department of Biochemistry Bushenyi Western Region Kampala International University - Western Campus
2 shared publications - Regan Mujinya
Department of Physiology Masaka Equator University of Science and Technology
2 shared publications - Swase Dominic Terkimbi
Department of Pharmacy, Faculty of Health Sciences Victoria University Kampala Uganda
2 shared publications - Bot Yakubu Sunday
Kampala International University, Western Campus
1 shared publication Buyinza Nicholas
Department of pharmacy Kampala middle 21 Victoria university kampala
1 shared publication
Latest Publications
- 15 October 2026
- Published by Elsevier in Next Research
- Vol. 14
Indigenous knowledge and scientific evidence of medicinal plants used in malaria treatment in Uganda: A systematic review
- 15 October 2026
- Published by Elsevier in Next Research
- Vol. 14
Indigenous knowledge and scientific evidence of medicinal plants used in malaria treatment in Uganda: A systematic review
- 18 September 2026
- Published by Elsevier in Next Research
- Vol. 13
The role of molecular docking and network pharmacology in antimalarial drug discovery
- 18 September 2026
- Published by Elsevier in Next Research
- Vol. 13
The role of molecular docking and network pharmacology in antimalarial drug discovery
- 21 July 2026
- Published by Elsevier in Next Research
- Vol. 12
Therapeutic roles of plant-derived phytochemicals in malaria treatment: A systematic review
- 21 July 2026
- Published by Elsevier in Next Research
- Vol. 12
Therapeutic roles of plant-derived phytochemicals in malaria treatment: A systematic review
- 14 July 2026
- Published by Elsevier in Next Research
- Vol. 12
Plant-derived phytochemicals targeting oxidative stress and mitochondrial dysfunction in plasmodium falciparum
- 14 July 2026
- Published by Elsevier in Next Research
- Vol. 12
Plant-derived phytochemicals targeting oxidative stress and mitochondrial dysfunction in plasmodium falciparum
- Open Access
- 3 February 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 183
Mechanisms of Neuroimmune Interactions in Stress Physiology, Health Implications, and Emerging Therapeutic Targets.
Chronic stress provokes maladaptive neuroimmune responses that disrupt the balance between the central nervous system and immune regulation. Dysregulation of the hypothalamic pituitary adrenal (HPA) axis, sympathetic adrenal medullary (SAM) system, and peripheral immune circuits sustains microglial activation and pro-inflammatory cytokine release. The process is responsible for driving persistent neuroinflammation. These changes impair synaptic plasticity, compromise blood-brain barrier integrity, and predispose individuals to psychiatric illness, cognitive dysfunction, and systemic comorbidities. Recent advances reveal key molecular mechanisms, including glucocorticoid receptor resistance, epigenetic reprogramming, and cytokine-neurotransmitter cross-talk that explain how stress reshapes brain-immune communication. This review critically examines the evidence linking chronic stress to neuroimmune dysfunction, emphasizing both translational challenges and therapeutic opportunities. Emerging interventions such as cytokine blockade, microglial modulation, specialized pro-resolving mediators, neurosteroids, and microbiome-based strategies highlight the potential of mechanism-based treatments. However, clinical translation is hampered by heterogeneity in inflammatory phenotypes, limited biomarker validation, and insufficient longitudinal data. Future research must prioritize precision medicine approaches that integrate multi-omics profiling, sex- and hormone-specific analyses, and digital biosensing tools. By bridging neuroscience, immunology, and systems biology, targeted strategies can be developed to prevent and treat stress-related disorders more effectively.
- 3 February 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 183
Open AccessMechanisms of Neuroimmune Interactions in Stress Physiology, Health Implications, and Emerging Therapeutic Targets.
Chronic stress provokes maladaptive neuroimmune responses that disrupt the balance between the central nervous system and immune regulation. Dysregulation of the hypothalamic pituitary adrenal (HPA) axis, sympathetic adrenal medullary (SAM) system, and peripheral immune circuits sustains microglial activation and pro-inflammatory cytokine release. The process is responsible for driving persistent neuroinflammation. These changes impair synaptic plasticity, compromise blood-brain barrier integrity, and predispose individuals to psychiatric illness, cognitive dysfunction, and systemic comorbidities. Recent advances reveal key molecular mechanisms, including glucocorticoid receptor resistance, epigenetic reprogramming, and cytokine-neurotransmitter cross-talk that explain how stress reshapes brain-immune communication. This review critically examines the evidence linking chronic stress to neuroimmune dysfunction, emphasizing both translational challenges and therapeutic opportunities. Emerging interventions such as cytokine blockade, microglial modulation, specialized pro-resolving mediators, neurosteroids, and microbiome-based strategies highlight the potential of mechanism-based treatments. However, clinical translation is hampered by heterogeneity in inflammatory phenotypes, limited biomarker validation, and insufficient longitudinal data. Future research must prioritize precision medicine approaches that integrate multi-omics profiling, sex- and hormone-specific analyses, and digital biosensing tools. By bridging neuroscience, immunology, and systems biology, targeted strategies can be developed to prevent and treat stress-related disorders more effectively.
- Open Access
- 9 December 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1384
Integrative Network Pharmacology and Molecular Docking Approaches in Herbal Medicine Research. A Systematic Review of Applications, Advances, and Translational Potential
Background Network pharmacology and molecular docking have emerged as important in modern herbal drug discovery, offering systems-level understanding into phytochemical interactions and therapeutic mechanisms. This review aimed to evaluate the application of integrated network pharmacology and molecular docking in herbal medicine research Methods A systematic search was conducted across PubMed, Scopus, and Web of Science for studies published between 2010 and August, 2025. Eligible studies included both network pharmacology and molecular docking in medicinal plants, botanical formulations, or isolated phytochemicals. Screening and selection followed PRISMA-ScR guidelines. Data were extracted on study characteristics, computational platforms, biological validation strategies, phytochemical profiles, protein targets, and mechanistic pathways. Results 36 studies met the eligibility criteria. Publications increased significantly after 2020, with most originating from Asia, particularly China (55.6%) and India (25.0%). Majority (61.1%) employed purely in silico pipelines, while 22.2% combined computational and in vitro validation, and 16.7% incorporated in vivo models. Flavonoids such as quercetin, kaempferol, apigenin, and luteolin accounted for most docked phytochemicals. Key molecular targets included ESR1, EGFR, AKT1, TNF, CASP3, and PTGS2, aligning predominantly with cancer, inflammatory, and metabolic pathways. Key signaling cascades PI3K-Akt, MAPK/ERK, NF-κB, and Wnt/β-catenin were consistently reported. Almost half of the studies (47.2%) integrated molecular dynamics simulations, while ADMET screening was reported in 71.4% of cases. Conclusion This review demonstrates that integrated network pharmacology and molecular docking have become foundational in herbal medicine research and growing with advances in computational biology. These approaches reveal multi-target mechanisms supporting the therapeutic potential of phytochemicals, yet translational progress is constrained by inconsistent pipelines. Strengthening validation frameworks, broadening phytochemical discovery beyond common flavonoids, and enhancing global research participation will be essential to accelerate clinically relevant herbal drug development.
- 9 December 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1384
Open AccessIntegrative Network Pharmacology and Molecular Docking Approaches in Herbal Medicine Research. A Systematic Review of Applications, Advances, and Translational Potential
Background Network pharmacology and molecular docking have emerged as important in modern herbal drug discovery, offering systems-level understanding into phytochemical interactions and therapeutic mechanisms. This review aimed to evaluate the application of integrated network pharmacology and molecular docking in herbal medicine research Methods A systematic search was conducted across PubMed, Scopus, and Web of Science for studies published between 2010 and August, 2025. Eligible studies included both network pharmacology and molecular docking in medicinal plants, botanical formulations, or isolated phytochemicals. Screening and selection followed PRISMA-ScR guidelines. Data were extracted on study characteristics, computational platforms, biological validation strategies, phytochemical profiles, protein targets, and mechanistic pathways. Results 36 studies met the eligibility criteria. Publications increased significantly after 2020, with most originating from Asia, particularly China (55.6%) and India (25.0%). Majority (61.1%) employed purely in silico pipelines, while 22.2% combined computational and in vitro validation, and 16.7% incorporated in vivo models. Flavonoids such as quercetin, kaempferol, apigenin, and luteolin accounted for most docked phytochemicals. Key molecular targets included ESR1, EGFR, AKT1, TNF, CASP3, and PTGS2, aligning predominantly with cancer, inflammatory, and metabolic pathways. Key signaling cascades PI3K-Akt, MAPK/ERK, NF-κB, and Wnt/β-catenin were consistently reported. Almost half of the studies (47.2%) integrated molecular dynamics simulations, while ADMET screening was reported in 71.4% of cases. Conclusion This review demonstrates that integrated network pharmacology and molecular docking have become foundational in herbal medicine research and growing with advances in computational biology. These approaches reveal multi-target mechanisms supporting the therapeutic potential of phytochemicals, yet translational progress is constrained by inconsistent pipelines. Strengthening validation frameworks, broadening phytochemical discovery beyond common flavonoids, and enhancing global research participation will be essential to accelerate clinically relevant herbal drug development.